IAEA COVID-19 project draws more than $28 million in funding

May 15, 2020, 11:24AMNuclear News

A health worker at the IAEA Seibersdorf Laboratories in Austria packs a COVID-19 support equipment package, which includes personal protective equipment, PCR machines, reagents, and laboratory consumables. Photo: D. Calma/IAEA

An initiative by the International Atomic Energy Agency to help nearly 120 countries contain the COVID-19 pandemic has received a financial boost from member states and Takeda Pharmaceutical Company Limited.

The IAEA announced on May 13 that Takeda, a biopharmaceutical company based in Tokyo, donated 500 million yen (about US$4.7 million). Two days earlier, the IAEA announced that pledges from more than 10 member nations totaled €22 million (about US$23.8 million).

To continue reading, log in or create a free account!

Related Articles

WANO names Spain’s Gago as new chair

October 24, 2024, 7:01AMNuclear News

The governing board of the World Association of Nuclear Operators has appointed José Gago as the new WANO chair. He was formerly the general manager and chief executive officer of the...

October 11, 1954: The founding of ANS

October 11, 2024, 9:19AMANS News

This year marks the 70th anniversary of the founding of the American Nuclear Society.Plenty of sources incorrectly list our birthday, but the reality is that October 11, 1954, is the correct...